Skip Navigation

Spondylarthropathies

Citations 171-180 of 281 total displayed.

Past content (since Apr 2000):

CLINICAL
Recurrence risk for psoriasis and psoriatic arthritis within sibships
A. Myers, L. J. Kay, S. A. Lynch, and D. J. Walker
Rheumatology 2005; 44: 773-776. [Abstract] [Full Text]  

CLINICAL
Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives
A. Spoorenberg, A. van Tubergen, R. Landewé, M. Dougados, S. van der Linden, H. Mielants, H. van de Tempel, and D. van der Heijde
Rheumatology 2005; 44: 789-795. [Abstract] [Full Text]  

LETTERS TO THE EDITOR
Lack of association of SLC22A4, SLC22A5, SLC9A3R1 and RUNX1 variants in psoriatic arthritis
C. Butt, S. Sun, C. Greenwood, D. Gladman, and P. Rahman
Rheumatology 2005; 44: 820-821. [Extract] [Full Text]  

REVIEWS
Patient-assessed health in ankylosing spondylitis: a structured review
K. L. Haywood, A. M. Garratt, and P. T. Dawes
Rheumatology 2005; 44: 577-586. [Abstract] [Full Text]  

CLINICAL
Validity and reliability of an Italian version of the revised Leeds disability questionnaire for patients with ankylosing spondylitis
E. Lubrano, P. Sarzi Puttini, W. J. Parsons, S. D'Angelo, M. A. Cimmino, F. Serino, and N. Pappone
Rheumatology 2005; 44: 666-669. [Abstract] [Full Text] [ Supplementary data ]  

LETTERS TO THE EDITOR
Corneodesmosin polymorphisms in psoriatic arthritis
C. Butt, P. Rahman, F. Siannis, V. T. Farewell, and D. D. Gladman
Rheumatology 2005; 44: 684-685. [Extract] [Full Text]  

CASE REPORTS
Survival and safety of treatment with infliximab in the elderly population
H. Chevillotte-Maillard, P. Ornetti, R. Mistrih, C. Sidot, J. Dupuis, J.-A. Dellas, C. Tavernier, and J. F. Maillefert
Rheumatology 2005; 44: 695-696. [Extract] [Full Text]  

CLINICAL
Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis
J. Brandt, J. Listing, H. Haibel, H. Sörensen, A. Schwebig, M. Rudwaleit, J. Sieper, and J. Braun
Rheumatology 2005; 44: 342-348. [Abstract] [Full Text]  

GUIDELINES
Guideline for anti-TNF-{alpha} therapy in psoriatic arthritis
S. Kyle, D. Chandler, C. E. M. Griffiths, P. Helliwell, J. Lewis, I. McInnes, S. Oliver, D. Symmons, and N. McHugh on behalf of the British Society for Rheumatology Standards Guidelines Audit Working Group
Rheumatology 2005; 44: 390-397. [Extract] [Full Text] [ Supplementary data ]  

CASE REPORTS
Infliximab-induced cerebral thrombophlebitis
L. Grange, M. J. Nissen, K. Garambois, A. Dumolard, C. Duc, P. Gaudin, and R. Juvin
Rheumatology 2005; 44: 260-261. [Extract] [Full Text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

* Collected Resources Home

* Related collections:
 Rheumatology
 Benign Joint Hypermobility Syndrome
 Crystal Arthritis
 Diagnostics and Imaging Procedures
 Education
 Experimental Arthritis
 Fibromyalgia
 Health Economics
 Historical Medicine
 Immunogenetics
 Myositis and Muscle Disease
 Osteoarthritis and Cartilage
 Osteoporosis and Metabolic Bone Disease
 Pharmacology
 Pregnancy and Rheumatic Diseases
 Psychology: Measurement and Management of Pain
 Rehabilitation
 Rheumatoid Arthritis
 Sjogren's Syndrome
 Soft Tissue Rheumatism
 Spinal Pain
 Spondylarthropathies
 Systemic Lupus Erythematosus and Autoimmunity
 Systemic Sclerosis
 Vasculitis